A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
Applying to 701, UCSD Antiviral Research Center CRS · San Diego, California
Answer a few short questions to share with the research team.